These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 33078933)
1. Discovery of Koralewski R; Dymek B; Mazur M; Sklepkiewicz P; Olejniczak S; Czestkowski W; Matyszewski K; Andryianau G; Niedziejko P; Kowalski M; Gruza M; Borek B; Jedrzejczak K; Bartoszewicz A; Pluta E; Rymaszewska A; Kania M; Rejczak T; Piasecka S; Mlacki M; Mazurkiewicz M; Piotrowicz M; Salamon M; Zagozdzon A; Napiorkowska-Gromadzka A; Bartlomiejczak A; Mozga W; Dobrzański P; Dzwonek K; Golab J; Nowotny M; Olczak J; Golebiowski A J Med Chem; 2020 Dec; 63(24):15527-15540. PubMed ID: 33078933 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of CHIT1 as a novel therapeutic approach in idiopathic pulmonary fibrosis. Sklepkiewicz P; Dymek BA; Mlacki M; Koralewski R; Mazur M; Nejman-Gryz P; Korur S; Zagozdzon A; Rymaszewska A; von der Thüsen JH; Siwińska AM; Güner NC; Cheda Ł; Paplinska-Goryca M; Proboszcz M; van den Bosch TPP; Górska K; Golab J; Kamiński RM; Krenke R; Golebiowski A; Dzwonek K; Dobrzanski P Eur J Pharmacol; 2022 Mar; 919():174792. PubMed ID: 35122869 [TBL] [Abstract][Full Text] [Related]
3. Development of Dual Chitinase Inhibitors as Potential New Treatment for Respiratory System Diseases. Mazur M; Dymek B; Koralewski R; Sklepkiewicz P; Olejniczak S; Mazurkiewicz M; Piotrowicz M; Salamon M; Jędrzejczak K; Zagozdzon A; Czestkowski W; Matyszewski K; Borek B; Bartoszewicz A; Pluta E; Rymaszewska A; Mozga W; Stefaniak F; Dobrzański P; Dzwonek K; Golab J; Golebiowski A; Olczak J J Med Chem; 2019 Aug; 62(15):7126-7145. PubMed ID: 31291098 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal and Comparative Measures of Serum Chitotriosidase and YKL-40 in Patients With Idiopathic Pulmonary Fibrosis. Majewski S; Szewczyk K; Jerczyńska H; Miłkowska-Dymanowska J; Białas AJ; Gwadera Ł; Piotrowski WJ Front Immunol; 2022; 13():760776. PubMed ID: 35222369 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of Macrophage-Specific CHIT1 as an Approach to Treat Airway Remodeling in Severe Asthma. Sklepkiewicz P; Dymek B; Mlacki M; Zagozdzon A; Salamon M; Siwińska AM; Mazurkiewicz MP; de Souza Xavier Costa N; Mazur M; Mauad T; Gołębiowski A; Dzwonek K; Gołąb J; Zasłona Z Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902148 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis. Dymek B; Sklepkiewicz P; Mlacki M; Güner NC; Nejman-Gryz P; Drzewicka K; Przysucha N; Rymaszewska A; Paplinska-Goryca M; Zagozdzon A; Proboszcz M; Krzemiński Ł; von der Thüsen JH; Górska K; Dzwonek K; Zasłona Z; Dobrzanski P; Krenke R J Inflamm Res; 2022; 15():5621-5634. PubMed ID: 36199746 [TBL] [Abstract][Full Text] [Related]
7. Chitinase 1: a novel therapeutic target in metabolic dysfunction-associated steatohepatitis. Cha JH; Park NR; Cho SW; Nam H; Yang H; Jung ES; Jang JW; Choi JY; Yoon SK; Sung PS; Bae SH Front Immunol; 2024; 15():1444100. PubMed ID: 39381000 [TBL] [Abstract][Full Text] [Related]
8. Chitinases and Chitinase-Like Proteins as Therapeutic Targets in Inflammatory Diseases, with a Special Focus on Inflammatory Bowel Diseases. Mazur M; Zielińska A; Grzybowski MM; Olczak J; Fichna J Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203467 [TBL] [Abstract][Full Text] [Related]
9. Analyzing airway inflammation with chemical biology: dissection of acidic mammalian chitinase function with a selective drug-like inhibitor. Sutherland TE; Andersen OA; Betou M; Eggleston IM; Maizels RM; van Aalten D; Allen JE Chem Biol; 2011 May; 18(5):569-79. PubMed ID: 21609838 [TBL] [Abstract][Full Text] [Related]
10. Chitotriosidase is the primary active chitinase in the human lung and is modulated by genotype and smoking habit. Seibold MA; Donnelly S; Solon M; Innes A; Woodruff PG; Boot RG; Burchard EG; Fahy JV J Allergy Clin Immunol; 2008 Nov; 122(5):944-950.e3. PubMed ID: 18845328 [TBL] [Abstract][Full Text] [Related]
11. Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis. Lee JH; Lee CM; Lee JH; Kim MO; Park JW; Kamle S; Akosman B; Herzog EL; Peng XY; Elias JA; Lee CG Am J Respir Cell Mol Biol; 2022 Sep; 67(3):309-319. PubMed ID: 35679109 [TBL] [Abstract][Full Text] [Related]
12. Discovery of 4-Methylquinazoline Based PI3K Inhibitors for the Potential Treatment of Idiopathic Pulmonary Fibrosis. Lin S; Jin J; Liu Y; Tian H; Zhang Y; Fu R; Zhang J; Wang M; Du T; Ji M; Wu D; Zhang K; Sheng L; Li Y; Chen X; Xu H J Med Chem; 2019 Oct; 62(19):8873-8879. PubMed ID: 31335136 [TBL] [Abstract][Full Text] [Related]
13. The Bleomycin Model of Pulmonary Fibrosis. Liu T; De Los Santos FG; Phan SH Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192 [TBL] [Abstract][Full Text] [Related]
14. Novel Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis: A Clinical Candidate Discovered Using DNA-Encoded Chemistry. Cuozzo JW; Clark MA; Keefe AD; Kohlmann A; Mulvihill M; Ni H; Renzetti LM; Resnicow DI; Ruebsam F; Sigel EA; Thomson HA; Wang C; Xie Z; Zhang Y J Med Chem; 2020 Jul; 63(14):7840-7856. PubMed ID: 32584034 [TBL] [Abstract][Full Text] [Related]
15. Discovery of Novel Selective and Orally Bioavailable Phosphodiesterase-1 Inhibitors for the Efficient Treatment of Idiopathic Pulmonary Fibrosis. Wu Y; Tian YJ; Le ML; Zhang SR; Zhang C; Huang MX; Jiang MY; Zhang B; Luo HB J Med Chem; 2020 Jul; 63(14):7867-7879. PubMed ID: 32603117 [TBL] [Abstract][Full Text] [Related]
16. Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma. Mazur M; Olczak J; Olejniczak S; Koralewski R; Czestkowski W; Jedrzejczak A; Golab J; Dzwonek K; Dymek B; Sklepkiewicz PL; Zagozdzon A; Noonan T; Mahboubi K; Conway B; Sheeler R; Beckett P; Hungerford WM; Podjarny A; Mitschler A; Cousido-Siah A; Fadel F; Golebiowski A J Med Chem; 2018 Feb; 61(3):695-710. PubMed ID: 29283260 [TBL] [Abstract][Full Text] [Related]
17. Discovery of CC-930, an orally active anti-fibrotic JNK inhibitor. Plantevin Krenitsky V; Nadolny L; Delgado M; Ayala L; Clareen SS; Hilgraf R; Albers R; Hegde S; D'Sidocky N; Sapienza J; Wright J; McCarrick M; Bahmanyar S; Chamberlain P; Delker SL; Muir J; Giegel D; Xu L; Celeridad M; Lachowitzer J; Bennett B; Moghaddam M; Khatsenko O; Katz J; Fan R; Bai A; Tang Y; Shirley MA; Benish B; Bodine T; Blease K; Raymon H; Cathers BE; Satoh Y Bioorg Med Chem Lett; 2012 Feb; 22(3):1433-8. PubMed ID: 22244937 [TBL] [Abstract][Full Text] [Related]
18. Discovery of novel pyrrolo[2,1-c][1,4]benzodiazepine-3,11-dione (PBD) derivatives as selective HDAC6 inhibitors for the efficient treatment of idiopathic pulmonary fibrosis (IPF) in vitro and in vivo. Li Y; Yang H; Zhao X; Zhao X; Quan J; Wang L; Ma E; Ma C Eur J Med Chem; 2024 Sep; 275():116608. PubMed ID: 38905805 [TBL] [Abstract][Full Text] [Related]
19. Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis. Günther S; Bordenave J; Hua-Huy T; Nicco C; Cumont A; Thuillet R; Tu L; Quatremarre T; Guilbert T; Jalce G; Batteux F; Humbert M; Savale L; Guignabert C; Dinh-Xuan AT Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567353 [TBL] [Abstract][Full Text] [Related]
20. Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis. Tzilas V; Bouros E; Barbayianni I; Karampitsakos T; Kourtidou S; Ntassiou M; Ninou I; Aidinis V; Bouros D; Tzouvelekis A Pulm Pharmacol Ther; 2019 Apr; 55():17-24. PubMed ID: 30659895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]